Cytiva, Pall to invest $1.5B in biomanufacturing over next 2 years
Cytiva and Pall, both Danaher companies, will make major investments in manufacturing capacity and services at 13 sites around the globe supporting life science customers, totaling $1.5 billion over two years. Read More
Bio-Techne launches multiplex spatial genomics assay
Bio-Techne has expanded its RNAscope in situ hybridization technology portfolio with the release of the new RNAscope HiPlex V2 assay for formalin-fixed, paraffin-embedded and fixed and frozen samples for up to 12 targets. Read More
Optogenetic gene therapy provides hope for retinitis pigmentosa patients
Optogenetic therapy bypasses traditional methods of repairing defective photoreceptors in the eye by targeting other retinal cells. Recently, three examples of optogenetic therapeutics under development highlight many of the challenges this type of gene therapy faces for the treatment of a devastating genetic eye disease. Read More
PerkinElmer posts growth in Q2
PerkinElmer posted revenue and operating income increases in its second quarter 2021. Read More
Collaborative Drug Discovery launches new drug database
Collaborative Drug Discovery has launched a new database called BioHarmony that offers continually updated drug data from a variety of sources. Read More
Twist incorporates Molcure AI into antibody discovery efforts
Twist Bioscience announced that it has used Molcure's artificial intelligence (AI) technology to generate new cancer antibodies. Read More
Slingshot Biosciences raises $23M for synthetic cell platform
Slingshot Biosciences announced the closing of $23 million in series A financing to fund the company's synthetic cell products portfolio. Read More
Danaher reports earnings, revenue increases in Q2
Danaher announced earnings and revenue increases for its second quarter of 2021. Read More
Wheeler Bio launches as antibody biomanufacturing company
Biotechnology ecosystem company Alloy Therapeutics and investment firm Echo Investment Capital announced the launch of Wheeler Bio, a new biomanufacturing company. Read More
AavantiBio, Aldevron partner on gene therapy
Aldevron made a deal to supply plasmid DNA that will enable AavantiBio to advance its gene therapies for rare genetic diseases. Read More
Conferences
CPhI North America
August 10-12
Philadelphia, Pennsylvania United States
Bioprocessing Summit
August 16-19
Boston, Massachusetts United States
6th Annual CAR-TCR Summit
August 30 - September 2
Online
European Congress of Immunology (ECI) 2021
September 1-4
Belgrade Serbia
Medical Affairs Strategic Summit (MASS)
September 13-15
New Brunswick, New Jersey United States
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter